NCT00264420View on ClinicalTrials.gov

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

March 31, 2007

Conditions

Bone MetastasesBreast CancerLung CancerProstate Cancer

Interventions

DRUG

zoledronic acid

At baseline 4 mg IV zoledronic acid over 15 min. every 4 weeks for 6 months plus radiation therapy 30 Gy in 10 fractions (5 times per week for first two weeks)